Search Results 21-30 of 11777 for Hypocalcemia

  1. ENPP1 variants associated with autosomal recessive hypophosphatemic rickets type 2: A case from the endocrine teaching clinics

    The patient returned to Mayo Clinic at age 52 with intermittent symptomatic hypocalcemia, persistent hypophosphatemia and a normal PTH . Her family history ...

  2. A Phase 3 Randomized Clinical Trial To Investigate The Safety And Efficacy Of Palopegteriparatide At Doses Greater Than 30 Μg/Day In Adult Participants With Hypoparathyroidism - Mayo Clinic

    Documented hypocalcemia within 12 weeks prior to Screening; and/or Standing dose of calcitriol ≥0.25 μg/day, and / or (elemental) calcium ≥1500 mg/day ...

  3. Publications - Adrian G. Dumitrascu, M.D. - Mayo Clinic

    Chindris AM, Dahiya R, Heckman MG, Sledge HJ, Desai K, Bernet VJ, Rao SN, Dumitrascu AG, Ozgursoy SK, Janus JR, Casler JD, Abate EG. Hypocalcemia Post Total ...

  4. Hyperparathyroidism - Symptoms & causes - Mayo Clinic

    The parathyroid glands make parathyroid hormone. The body has four of these glands. They are located behind the thyroid gland at the bottom of the neck. Each ...

  5. Hypoparathyroidism Clinical Trials - Mayo Clinic Research

    ... Hypocalcemia Type 1 (ADH1). Study To Assess The Blood Concentrations And Actions Of Recombinant Human Parathyroid Hormone (RhPTH [1-84]) When Given Once And ...

  6. Hyperparathyroidism - Diagnosis & treatment - Mayo Clinic

    Learn about symptoms, tests and treatment for this condition caused by overactivity of the parathyroid glands.

  7. Polyethylene glycol 3350, electrolytes, and ascorbic acid (oral route) - Side effects & dosage - Mayo Clinic

    Hypocalcemia (low calcium in the blood) or; Hypokalemia (low potassium in the blood) or; Hypomagnesemia (low magnesium in the blood) or; Hyponatremia (low ...

  8. Palopegteriparatide (subcutaneous route) - Side effects & dosage - Mayo Clinic

    Hypocalcemia (low levels of calcium in the blood)—Use with caution. May make these conditions worse. Back to top. Proper Use. A nurse or other trained health ...

  9. Recurrent primary hyperparathyroidism in a patient with multiple endocrine neoplasia, type 1: A case from the endocrine teaching clinics - Mayo Clinic

    He tolerated both procedures without complications such as hypocalcemia, hoarseness, bleeding or infection. Follow-up three years later shows that he ...

  10. Denosumab-adet (subcutaneous route) - Side effects & uses - Mayo Clinic

    Hypocalcemia (low calcium in the blood)—Should not be given to patients with this condition. Back to top. Proper Use. A doctor or other trained health ...